Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

The Analgesic Efficacy of Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04213924

Enrollment

Registered

2019-12-30

Start date

2020-06-01

Completion date

2020-10-01

Last updated

2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Urinary System Stones

Keywords

Extracorporeal Shockwave Lithotripsy, Erector Spinae Plane Block

Brief summary

Extracorporeal shock wave lithotripsy (ESWL) is widely used in the treatment of urinary tract stones and is generally applied to outpatients. To achieve fragmentation in ESWL, shock waves must be applied with sufficient power and time. Providing effective analgesia during this procedure is crucial to the success of the procedure. Erector Spinae Plan Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in urinary system surgery. This study aimed to investigate the efficacy of ESPB in patients undergoing ESWL.

Interventions

DRUGBupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml

Erector spinae plane block, 30 min before the ESWL procedure.

DRUG5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously

5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously, 30 min before the ESWL procedure.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* American Society of Anesthesiologist's physiologic state I-II patients undergoing Extracorporeal Shockwave Lithotripsy

Exclusion criteria

* chronic pain * bleeding disorders * renal or hepatic insufficiency * patients on chronic non-steroidal anti-inflammatory medications * emergency cases

Design outcomes

Primary

Measure	Time frame	Description
Opioid Consumption	Intraoperative 30 minutes	Opioid consumption during procedure

Secondary

Measure	Time frame	Description
Visual Analog Pain Score	Intraoperative 30 minutes	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Countries

Turkey (Türkiye)

Contacts

Primary ContactAhmet Yayik, MD

m_yayik@hotmail.com00905544259287

Backup ContactAli Ahiskalioglu, MD

aliahiskalioglu@hotmail.com00905444424831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026